![Joseph E. Lehnen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joseph E. Lehnen
Profile
Joseph E.
Lehnen served as Chief Financial Officer at Perlegen Sciences, Inc., MaxCyte, Inc., and InforMax Software.
He was also President at Netchoicetv, Inc. and President-Investment Banking at J.P.
Morgan & Co. Ltd.
Prior to that, he worked as a Principal at Strategic Capital Consultants, Inc. Lehnen holds a graduate degree from Harvard University and a graduate degree from Yale University.
He also holds an undergraduate degree from Santa Clara University.
Former positions of Joseph E. Lehnen
Companies | Position | End |
---|---|---|
J.P. Morgan & Co. Ltd. | Corporate Officer/Principal | - |
InforMax Software | Director of Finance/CFO | - |
Strategic Capital Consultants, Inc. | Corporate Officer/Principal | - |
Netchoicetv, Inc. | President | - |
MAXCYTE, INC. | Director of Finance/CFO | - |
Training of Joseph E. Lehnen
Harvard University | Graduate Degree |
Yale University | Graduate Degree |
Santa Clara University | Undergraduate Degree |
Experiences
Positions held
Linked companies
Listed companies | 1 |
---|---|
MAXCYTE, INC. | Health Technology |
Private companies | 5 |
---|---|
Perlegen Sciences, Inc.
![]() Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Retail Trade |
J.P. Morgan & Co. Ltd. | Finance |
Strategic Capital Consultants, Inc. | |
Netchoicetv, Inc. | |
InforMax Software |
- Stock Market
- Insiders
- Joseph E. Lehnen